- Home
- MRAM vs ANVS Comparison
MRAM vs ANVS Comparison
Compare MRAM & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRAM | ANVS |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.3M | 111.3M |
| IPO Year | 2016 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MRAM | ANVS |
|---|---|---|
| Price | $8.83 | $1.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $14.00 | $13.50 |
| AVG Volume (30 Days) | ★ 416.3K | 359.7K |
| Earning Date | 03-04-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 39.39 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $49,417,000.00 | N/A |
| Revenue This Year | $10.22 | N/A |
| Revenue Next Year | $7.38 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 37.51 | N/A |
| 52 Week Low | $4.34 | $1.11 |
| 52 Week High | $17.24 | $5.50 |
Technical Indicators
Market Signals| Indicator | MRAM | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 40.44 | 33.25 |
| Support Level | $8.50 | $1.97 |
| Resistance Level | $9.74 | $2.99 |
| Average True Range (ATR) | 0.47 | 0.22 |
| MACD | 0.06 | -0.05 |
| Stochastic Oscillator | 9.83 | 1.89 |
Price Performance
Historical ComparisonAbout MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a manufacturer of Magnetoresistive Random Access Memory (MRAM) technology. The company manufactures MRAM products using both captive and third-party manufacturing capabilities. It purchases industry-standard complementary metal-oxide semiconductor (CMOS) wafers from semiconductor foundries and perform back end of line (BEOL) processing that includes magnetic-bit technology at leased 200mm fabrication facility in Chandler, Arizona. It also manufactures full-flow 300mm CMOS wafers with STT-MRAM magnetic-bit technology integrated in BEOL. The company's customers are in key markets, such as industrial, medical, automotive/transportation, aerospace, and data center.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.